Your browser doesn't support javascript.
Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19.
Yong, Yean Kong; Wong, Won Fen; Vignesh, Ramachandran; Chattopadhyay, Indranil; Velu, Vijayakumar; Tan, Hong Yien; Zhang, Ying; Larsson, Marie; Shankar, Esaki M.
  • Yong YK; Laboratory Centre, Xiamen University Malaysia, Sepang, Malaysia.
  • Wong WF; Department of Medical Microbiology, Faculty Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Vignesh R; Preclinical Department, Royal College of Medicine Perak (UniKL RCMP), Universiti Kuala Lumpur, Ipoh, Malaysia.
  • Chattopadhyay I; Cancer and Microbiome Biology, Department of Life Sciences, Central University of Tamil Nadu, Thiruvarur, India.
  • Velu V; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States.
  • Tan HY; Department of Pathology and Laboratory Medicine, Emory National Primate Research Center, Emory University, Atlanta GA, United States.
  • Zhang Y; School of Traditional Chinese Medicine, Xiamen University Malaysia, Sepang, Malaysia.
  • Larsson M; Chemical Engineering, Xiamen University Malaysia, Sepang, Malaysia.
  • Shankar EM; Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Front Immunol ; 13: 889196, 2022.
Article in English | MEDLINE | ID: covidwho-1957157
ABSTRACT
The dynamics of host-virus interactions, and impairment of the host's immune surveillance by dengue virus (DENV) serotypes largely remain ambiguous. Several experimental and preclinical studies have demonstrated how the virus brings about severe disease by activating immune cells and other key elements of the inflammatory cascade. Plasmablasts are activated during primary and secondary infections, and play a determinative role in severe dengue. The cross-reactivity of DENV immune responses with other flaviviruses can have implications both for cross-protection and severity of disease. The consequences of a cross-reactivity between DENV and anti-SARS-CoV-2 responses are highly relevant in endemic areas. Here, we review the latest progress in the understanding of dengue immunopathogenesis and provide suggestions to the development of target strategies against dengue.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dengue / Dengue Virus / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.889196

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dengue / Dengue Virus / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.889196